A Quick Snapshot Of Boston Scientific's Rhythm Management & Neuro Segment

Boston Scientific's (NYSE: BSX) Rhythm Management and Neuro segment accounts for around 30% of the company's value, according to our estimates. The segment includes products such as pacemakers, implantable cardioverter defibrillators (ICDs), and electrophysiology products. The segment has...